Processa Pharmaceuticals (PCSA) Q2 2024 Earnings

10MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-1.18
-0.81
-0.45
-0.08

Details

Expected EPS
-1.18
Actual EPS
-1.11
Surprise EPS
0.07
Surprise Percent
+5.93%

Description

Processa Pharmaceuticals (PCSA) has reported earnings of -1.11 per share for Q2 2024.

0 Comments

Share your thoughts